Collectively, these findings suggest that IRF5 regulates lung cancer cell growth through its interaction with HLA‐E, wherein overexpression of HLA‐E can counteract the tumor‐promoting effects induced by si‐IRF5 M1‐exos. The gene discussed is HLA-E; the disease is lung carcinoma.